Comment on: "Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder"

CNS Drugs. 2023 Oct;37(10):937-938. doi: 10.1007/s40263-023-01034-3. Epub 2023 Sep 1.
No abstract available

Publication types

  • Letter
  • Comment